CLINICAL_TRIALS
trial_result
· 2025-02-05
Clinical Trial Update: A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India [Phase 4]
Summary
Phase 4 clinical trial evaluating dulaglutide (LY2189265) in participants with Type 2 diabetes mellitus in India has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2025-02-05